Patent & Technology License Agreement Sample Contracts

PATENT & Technology LICENSE AGREEMENT AGT. No. A2014-0164
Patent & Technology License Agreement • December 22nd, 2015 • American Boarding Co • Real estate • Ohio

This Patent & Technology License Agreement is between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).

Sample 1Sample 2Sample 3See All (12)
AutoNDA by SimpleDocs
OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION CONFIDENTIAL TREATMENT REQUESTED PATENT & Technology LICENSE AGREEMENT AGT. No. A2014-0294
Patent & Technology License Agreement • May 5th, 2020

This Patent & Technology License Agreement is between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).

Sample 1Sample 2Sample 3See All (4)
PATENT & TECHNOLOGY LICENSE AGREEMENT [use for Exclusive Licenses to technology solely owned by Board and made solely at MDA with Patent Applications on file]
Patent & Technology License Agreement • May 15th, 2012 • Texas

This Patent and Technology License Agreement (“Agreement”) is by and between The Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas, whose address is 210 West 7th Street, Austin, Texas 78701, on behalf of The University of Texas M. D. Anderson Cancer Center (“MD Anderson”), a member institution of System, and [Company name], a [jurisdiction] [corporation/LLC/etc.], with its principal place of business at _____________ (“Licensee”) (collectively, “Parties”, or singly, “Party”).

Sample 1Sample 2Sample 3
PATENT & TECHNOLOGY LICENSE AGREEMENT
Patent & Technology License Agreement • May 14th, 2020 • ADiTx Therapeutics, Inc. • Pharmaceutical preparations • California

This Patent and Technology License Agreement (“Agreement”) is effective on March 15, 2018 (the “Effective Date”) and is entered by and between Loma Linda University (“LLU”), a California Religious Institution, whose address is 24887 Taylor Street, Suite 201, Loma Linda, California 92354, and ADiTx Therapeutics, Inc., a Delaware C Corporation, with its principal place of business at 11161 Anderson St., Suite 105-10014, Loma Linda, CA 92354 (“Licensee”) (collectively, “Parties”, or singly, “Party”).

Sample 1Sample 2Sample 3
PATENT & TECHNOLOGY LICENSE AGREEMENT AGT. NO. L2664-MAIA BIOTECHNOLOGY
Patent & Technology License Agreement • April 11th, 2022 • MAIA Biotechnology, Inc. • Pharmaceutical preparations • Texas

This Patent and Technology License Agreement (“Agreement”) is between The Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas whose address is 210 West 7th Street, Austin, Texas 78701 on behalf of The University of Texas Southwestern Medical Center (“UT Southwestern”), a component institution of System, whose address is 5323 Harry Hines Boulevard, Dallas, Texas 75390-9094 (“Licensor”) and MAIA Biotechnology, Inc., a Delaware corporation, with its principal place of business at 444 West Lake Street, Suite 1700, Chicago, IL 60606 (“Licensee”) (collectively, “Parties”, or singly, “Party”).

Sample 1Sample 2
PATENT & TECHNOLOGY LICENSE AGREEMENT AGT. NO. L3648-MAIA BIOTECHNOLOGY
Patent & Technology License Agreement • April 11th, 2022 • MAIA Biotechnology, Inc. • Pharmaceutical preparations • Texas

This Patent and Technology License Agreement (“Agreement”) is between The Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas whose address is 210 West 7th Street, Austin, Texas 78701 on behalf of The University of Texas Southwestern Medical Center (“UT Southwestern”), a component institution of System, whose address is 5323 Harry Hines Boulevard, Dallas, Texas 75390-9094 (“Licensor”) and MAIA Biotechnology, Inc., a Delaware corporation, with its principal place of business at 444 West Lake Street, Suite 1700, Chicago, IL 60606 (“Licensee”) (collectively, “Parties”, or singly, “Party”).

Sample 1Sample 2
PATENT & TECHNOLOGY LICENSE AGREEMENT AGT. NO. D-XXXX
Patent & Technology License Agreement • March 21st, 2017 • Texas
Sample 1Sample 2
PATENT & TECHNOLOGY LICENSE AGREEMENT AGT. NO. L2664-MAIA BIOTECHNOLOGY
Patent & Technology License Agreement • May 31st, 2022 • MAIA Biotechnology, Inc. • Pharmaceutical preparations • Texas

This Patent and Technology License Agreement (“Agreement”) is between The Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas whose address is 210 West 7th Street, Austin, Texas 78701 on behalf of The University of Texas Southwestern Medical Center (“UT Southwestern”), a component institution of System, whose address is 5323 Harry Hines Boulevard, Dallas, Texas 75390-9094 (“Licensor”) and MAIA Biotechnology, Inc., a Delaware corporation, with its principal place of business at 444 West Lake Street, Suite 1700, Chicago, IL 60606 (“Licensee”) (collectively, “Parties”, or singly, “Party”).

Sample 1
PATENT & Technology LICENSE AGREEMENT AGT. No. HSC-1316-LA1
Patent & Technology License Agreement • May 12th, 2023 • Blue Water Biotech, Inc. • Pharmaceutical preparations • Texas

This Patent and Technology License Agreement is between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).

Sample 1
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions. AMENDED AND RESTATED...
Patent & Technology License Agreement • January 25th, 2024 • Aileron Therapeutics Inc • Pharmaceutical preparations • Texas

This Amended and Restated Patent and Technology License Agreement (“Agreement”), effective as of December 19, 2013, is between the Board of Regents of The University of Texas System, an agency of the State of Texas whose address is 201 West 7th St. Austin, TX 78701 (“Board”), on behalf of The University of Texas Health Science Center at Tyler (“UTHSCT”) (with Board on behalf of UTHSCT as “Licensor”), and Lung Therapeutics, Inc., a Texas Corporation, with its principal place of business at P.O. Box 150183, Austin, Texas 78715 (“Licensee”) (collectively, “Parties”, or singly, “Party”).

Sample 1
PATENT & TECHNOLOGY LICENSE AGREEMENT AGT. NO. ____________
Patent & Technology License Agreement • March 1st, 2010 • Texas

This Patent and Technology License Agreement (“Agreement”) is between [Insert name of institution], on behalf of [insert name of governing body], an agency of the State of Texas, whose address is (“Licensor”) and [Company name], a [jurisdiction] [corporation/LLC/etc.], with its principal place of business at _____________ (“Licensee”) (collectively, “Parties”, or singly, “Party”).

Sample 1
FIRST AMENDMENT TO THE PATENT & TECHNOLOGY LICENSE AGREEMENT
Patent & Technology License Agreement • August 13th, 2020 • ADiTx Therapeutics, Inc. • Pharmaceutical preparations

THIS FIRST AMENDMENT TO THE PATENT & TECHNOLOGY LICENSE AGREEMENT (the “Amendment”) is entered into and effective as of July 1, 2020 (the “Effective Date”) by and between Aditx Therapeutics, Inc., (the “Company”), and Loma Linda University (“LLU”).

Sample 1
PATENT & TECHNOLOGY LICENSE AGREEMENT AGT. NO. A2014-1834
Patent & Technology License Agreement • March 12th, 2019 • Cellectis S.A. • Biological products, (no disgnostic substances) • Ohio

This Patent & Technology License Agreement (“PTLA”) is by and between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).

Sample 1
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. PATENT & TECHNOLOGY LICENSE AGREEMENT AGT....
Patent & Technology License Agreement • October 24th, 2024 • Regulus Therapeutics Inc. • Pharmaceutical preparations • Texas

This Patent and Technology License Agreement (“Agreement”) is between The Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas whose address is 201 West 7th Street, Austin, Texas 78701 on behalf of The University of Texas Southwestern Medical Center (“UT Southwestern”), a component institution of System, whose address is 5323 Harry Hines Boulevard, Dallas, Texas 75390-9094 (“Licensor”) and Regulus Therapeutics Inc., a Delaware corporation, with its principal place of business at 4224 Campus Point Court, Suite 210, San Diego, CA 92121 (“Licensee”) (collectively, “Parties”, or singly, “Party”).

Sample 1
PATENT & TECHNOLOGY LICENSE AGREEMENT AGT. NO. A2014-1834
Patent & Technology License Agreement • March 12th, 2015 • Cellectis S.A. • Biological products, (no disgnostic substances) • Ohio

This Patent & Technology License Agreement (“PTLA”) is by and between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).

Sample 1
PATENT & TECHNOLOGY LICENSE AGREEMENT AGT. NO. L3648-MAIA BIOTECHNOLOGY
Patent & Technology License Agreement • May 31st, 2022 • MAIA Biotechnology, Inc. • Pharmaceutical preparations • Texas

This Patent and Technology License Agreement (“Agreement”) is between The Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas whose address is 210 West 7th Street, Austin, Texas 78701 on behalf of The University of Texas Southwestern Medical Center (“UT Southwestern”), a component institution of System, whose address is 5323 Harry Hines Boulevard, Dallas, Texas 75390-9094 (“Licensor”) and MAIA Biotechnology, Inc., a Delaware corporation, with its principal place of business at 444 West Lake Street, Suite 1700, Chicago, IL 60606 (“Licensee”) (collectively, “Parties”, or singly, “Party”).

Sample 1
Amendment No. 2 to Patent & Technology License Agreement
Patent & Technology License Agreement • November 9th, 2020 • LogicBio Therapeutics, Inc. • Biological products, (no disgnostic substances)

This Amendment No. 2 to Patent & Technology License Agreement (“Amendment Two”) is made and entered into as of September 29, 2020 (the “Effective Date”) by and between LogicBio Therapeutics, Inc. a Delaware corporation, having a principal place of business at 65 Hayden Avenue, Floor 2, Lexington, MA 02421 (“LogicBio”) and The Board of Regents (“Board”) of The University of Texas System (“System”, an agency of the State of Texas whose address is 210 West 7th Street, Austin, Texas 78701, on behalf of The University of Texas Southwestern Medical Center (“UT Southwestern”), a component institution of System, whose address is 5323 Harry Hines Boulevard, Dallas, Texas 75390-9094.

Sample 1
019956.000999 4887-3169-1385.15 1 NON-EXCLUSIVE PATENT & TECHNOLOGY LICENSE AGREEMENT This NON-EXCLUSIVE PATENT AND TECHNOLOGY LICENSE AGREEMENT (“Agreement”) dated as of October 6, 2023 (the “Effective Date”) is by and between SYSTEM73 LIMITED, a...
Patent & Technology License Agreement • October 10th, 2023 • Altisource Asset Management Corp • Real estate • England and Wales
Sample 1
Amendment No. 1 to Patent & Technology License Agreement
Patent & Technology License Agreement • March 16th, 2020 • LogicBio Therapeutics, Inc. • Biological products, (no disgnostic substances)

This Amendment No. 1 to Patent & Technology License Agreement (“Amendment One”) is made and entered into as of October 14, 2019 (the “Effective Date”) by and between LogicBio Therapeutics, Inc. a Delaware corporation, having a principal place of business at 99 Erie Street, Cambridge, MA 02139 (“LogicBio”) and The Board of Regents (“Board”) of The University of Texas System (“System”, an agency of the State of Texas whose address is 210 West 7th Street, Austin, Texas 78701, on behalf of The University of Texas Southwestern Medical Center (“UT Southwestern”), a component institution of System, whose address is 5323 Harry Hines Boulevard, Dallas, Texas 75390-9094.

Sample 1
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!